
|Videos|February 20, 2019
KRAS-Mutated Metastatic CRC
KRAS-Mutated Metastatic CRC
Advertisement
Case: A 38-year Old Woman WithKRAS-Mutated mCRC
Initial presentation
- A 38-year old woman was referred to gastroenterology after experiencing several bouts of bloody diarrhea
- PMH: unremarkable
- PE: unremarkable
Clinical workup
- Colonoscopy: suspicious sigmoid mass, partial obstruction
- Biopsy: poorly differentiated adenocarcinoma
- Imaging: CT scan of the chest/abdomen/pelvis revealed multiple small bilateral liver metastases
- Molecular testing on tissue biopsy:
- Positive forKRASexon 2 codon 12 mutation
- Negative forNRAS,BRAF
- Microsatellite-stable
- Diagnosis: stage IV colorectal cancer
- ECOG PS 0
Treatment
- She underwent laparoscopic sigmoid resection
- She was initiated on treatment with FOLFOX + bevacizumab; well-tolerated
- Follow-up imaging at 3 and 6 months showed a partial response
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
2
Dr Tolaney on SG + Pembrolizumab Biomarker Data in First-Line mTNBC
3
FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer
4
Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC
5































